Pain Processes in Tennis Elbow Visualized with PET scanning
By MedImaging International staff writers Posted on 11 Nov 2013 |
![Image: PET image of NK1 receptor radioligand [11C]GR205171 in a subject (Photo courtesy of Plos One, October 2013; Peterson M, Svärdsudd K, Appel L, et al.). Image: PET image of NK1 receptor radioligand [11C]GR205171 in a subject (Photo courtesy of Plos One, October 2013; Peterson M, Svärdsudd K, Appel L, et al.).](https://globetechcdn.com/mobile_medicalimaging/images/stories/articles/article_images/_MI/20131107 - JQR116.gif)
Image: PET image of NK1 receptor radioligand [11C]GR205171 in a subject (Photo courtesy of Plos One, October 2013; Peterson M, Svärdsudd K, Appel L, et al.).
The physiologic mechanisms in soft tissue pain such as chronic tennis elbow can now be seen clearly using the imaging technology positron emission tomography (PET), according to Swedish radiologists.
The new study was demonstrated by researchers from Uppsala University (Sweden), and the findings were published October 2013 in the journal PLOS ONE. Chronic pain is a significant problem, with substantial socioeconomic costs and suffering of the individual. Musculoskeletal pain is the most typical type of pain and is one of the most common reasons for consultation in health care. However, pain from soft tissues (i.e., pain from muscles, tendons, and ligaments) is still lacking effective approaches for localization and diagnosis of underlying pathophysiologic processes.
This means that diagnosis still depends on clinical examination, which provides no guidance regarding what mechanisms might underlie the pain. Therefore, treatment relies solely on an empirical basis. An improved diagnostic technique that allows not only diagnosis of localization of the painful tissue processes, but also can provide guidance regarding what pathophysiologic mechanisms are involved, would therefore be very valuable.
Dr. Magnus Peterson from Uppsala University is utilizing PET imaging in combination with a specific tracer for the signal receptor NK1 to visualize such injuries. The tracer is injected into the blood where it circulates through the body and binds to available NK1 receptors. The signal from the radioactive tracer can then be captured as an image outside the body using PET.
This is the first time an up-regulation of NK1 receptors has been visualized by diagnostic imaging in painful tissue in humans. The study distinctly reveals an image of elevated levels of NK1 in the painful area compared with the healthy arm.
Following tissue injury, there is an up-regulation of the neuropeptide substance P and its receptor NK1. This happens not only in the dorsal horn of the spinal cord, but also in the peripheral painful tissue. This up-regulation process is part of an interaction between peripheral nerves, immune cells, and the tissue itself that seems to help guide the body’s own repair process. In chronic tennis elbow, this up-regulation of the substance P-NK1 system lingers on. This is what the researchers have succeeded in visualizing with the aid of PET and the marker for NK1.
The technology has potential, but the procedure is still quite expensive. PET is a complex procedure, which requires high-end equipment. “In the future, we hope to be able to develop less expensive markers that enable us to use the method in everyday clinical practice. We also aim to create markers for other physiological processes that we know are active in chronic soft tissue pain,” concluded Dr. Peterson.
Related Links:
Uppsala University
The new study was demonstrated by researchers from Uppsala University (Sweden), and the findings were published October 2013 in the journal PLOS ONE. Chronic pain is a significant problem, with substantial socioeconomic costs and suffering of the individual. Musculoskeletal pain is the most typical type of pain and is one of the most common reasons for consultation in health care. However, pain from soft tissues (i.e., pain from muscles, tendons, and ligaments) is still lacking effective approaches for localization and diagnosis of underlying pathophysiologic processes.
This means that diagnosis still depends on clinical examination, which provides no guidance regarding what mechanisms might underlie the pain. Therefore, treatment relies solely on an empirical basis. An improved diagnostic technique that allows not only diagnosis of localization of the painful tissue processes, but also can provide guidance regarding what pathophysiologic mechanisms are involved, would therefore be very valuable.
Dr. Magnus Peterson from Uppsala University is utilizing PET imaging in combination with a specific tracer for the signal receptor NK1 to visualize such injuries. The tracer is injected into the blood where it circulates through the body and binds to available NK1 receptors. The signal from the radioactive tracer can then be captured as an image outside the body using PET.
This is the first time an up-regulation of NK1 receptors has been visualized by diagnostic imaging in painful tissue in humans. The study distinctly reveals an image of elevated levels of NK1 in the painful area compared with the healthy arm.
Following tissue injury, there is an up-regulation of the neuropeptide substance P and its receptor NK1. This happens not only in the dorsal horn of the spinal cord, but also in the peripheral painful tissue. This up-regulation process is part of an interaction between peripheral nerves, immune cells, and the tissue itself that seems to help guide the body’s own repair process. In chronic tennis elbow, this up-regulation of the substance P-NK1 system lingers on. This is what the researchers have succeeded in visualizing with the aid of PET and the marker for NK1.
The technology has potential, but the procedure is still quite expensive. PET is a complex procedure, which requires high-end equipment. “In the future, we hope to be able to develop less expensive markers that enable us to use the method in everyday clinical practice. We also aim to create markers for other physiological processes that we know are active in chronic soft tissue pain,” concluded Dr. Peterson.
Related Links:
Uppsala University
Latest Nuclear Medicine News
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
- New Immuno-PET Imaging Technique Identifies Glioblastoma Patients Who Would Benefit from Immunotherapy
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
Type 2 diabetes is recognized as an autoimmune inflammatory disease, where chronic inflammation leads to alterations in pancreatic islet microvasculature, a key factor in β-cell dysfunction.... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more